Survey of US Optometrists Reveals Large Number of Untreated Keratoconus Patients

Leah DeWitt 10/23/24 Leah DeWitt 10/23/24

Survey of US Optometrists Reveals Large Number of Untreated Keratoconus Patients

Jonathan H. Talamo, MD, Chair of the Board at Epion Therapeutics, Presents Optometric Survey Results at Eyecelerator @ AAO 2024

Read More

Epion Therapeutics' CMO, Michael W. Belin, MD, Shares Phase 3 Updates at Eyecelerator during ASCRS Conference

Leah DeWitt 4/8/24 Leah DeWitt 4/8/24

Epion Therapeutics' CMO, Michael W. Belin, MD, Shares Phase 3 Updates at Eyecelerator during ASCRS Conference

Read More

Epion Therapeutics Initiates Phase 3 Clinical Trials for Minimally-Invasive Keratoconus Treatment

Leah DeWitt 10/31/23 Leah DeWitt 10/31/23

Epion Therapeutics Initiates Phase 3 Clinical Trials for Minimally-Invasive Keratoconus Treatment

Read More

CXL Ophthalmics Announces New Name and Vision as Epion Therapeutics

Leah DeWitt 7/6/23 Leah DeWitt 7/6/23

CXL Ophthalmics Announces New Name and Vision as Epion Therapeutics

Read More

CXL Ophthalmics CEO Michael D. Webb to Present at 2023 BIO International Convention

Leah DeWitt 6/5/23 Leah DeWitt 6/5/23

CXL Ophthalmics CEO Michael D. Webb to Present at 2023 BIO International Convention

Read More

Dr. Ken Beckman Shares Insights on Groundbreaking Epithelium-On Cross-Linking Treatment at ASCRS Conference

Leah DeWitt 5/10/23 Leah DeWitt 5/10/23

Dr. Ken Beckman Shares Insights on Groundbreaking Epithelium-On Cross-Linking Treatment at ASCRS Conference

Read More

CXL Ophthalmics’ CMO To Deliver Plenary Session at 1st Annual International Keratoconus Academy Symposium

Leah DeWitt 4/21/23 Leah DeWitt 4/21/23

CXL Ophthalmics’ CMO To Deliver Plenary Session at 1st Annual International Keratoconus Academy Symposium

Read More

CXL Ophthalmics Appoints Tiffany Haynes as Vice President of Clinical Operations

Leah DeWitt 3/14/23 Leah DeWitt 3/14/23

CXL Ophthalmics Appoints Tiffany Haynes as Vice President of Clinical Operations

Read More

CXL Ophthalmics Appoints Jonathan Talamo, MD, as Chair of the Board

Leah DeWitt 1/18/23 Leah DeWitt 1/18/23

CXL Ophthalmics Appoints Jonathan Talamo, MD, as Chair of the Board

Read More

CXL Ophthalmics Announces $32 Million Series A Investment Round Led by AXA IM Alts, Through its Global Health Private Equity Strategy

Leah DeWitt 9/30/22 Leah DeWitt 9/30/22

CXL Ophthalmics Announces $32 Million Series A Investment Round Led by AXA IM Alts, Through its Global Health Private Equity Strategy

Read More

CXL Ophthalmics Publishes Results of EpiSmart® Cross-Linking Phase 2 Clinical Trial for Keratoconus in Cornea

Leah DeWitt 9/29/22 Leah DeWitt 9/29/22

CXL Ophthalmics Publishes Results of EpiSmart® Cross-Linking Phase 2 Clinical Trial for Keratoconus in Cornea

“The results of this study demonstrate the promise of our approach to cross-linking in halting the progression of keratoconus in patients and restoring vision with a minimally-invasive process”

Read More

CXL Ophthalmics Announces Results of Successful Phase 2 Clinical Trial in Epi-On Cross-linking for Keratoconus

Leah DeWitt 11/14/21 Leah DeWitt 11/14/21

CXL Ophthalmics Announces Results of Successful Phase 2 Clinical Trial in Epi-On Cross-linking for Keratoconus

Read More

CXL Ophthalmics Granted Patents on UV-A Device for Transepithelial (Epi-on) Corneal Cross-linking

Leah DeWitt 6/28/21 Leah DeWitt 6/28/21

CXL Ophthalmics Granted Patents on UV-A Device for Transepithelial (Epi-on) Corneal Cross-linking

Read More

CXL Ophthalmics Publishes Data Demonstrating Benefits of Ribostat™ for Transepithelial Cross-linking

Leah DeWitt 5/28/21 Leah DeWitt 5/28/21

CXL Ophthalmics Publishes Data Demonstrating Benefits of Ribostat™ for Transepithelial Cross-linking

Read More

CXL Ophthalmics Appoints Jonathan H. Talamo, MD to its Board of Managers

Leah DeWitt 4/29/20 Leah DeWitt 4/29/20

CXL Ophthalmics Appoints Jonathan H. Talamo, MD to its Board of Managers

Read More

Phase 2 Enrollment Complete

Leah DeWitt 7/1/19 Leah DeWitt 7/1/19

Phase 2 Enrollment Complete

Read More

Ribostat™ Research Presented at ARVO 2019

Leah DeWitt 5/1/19 Leah DeWitt 5/1/19

Ribostat™ Research Presented at ARVO 2019

Read More

EpiSmart™ Clinical Data Published in JCRS

Leah DeWitt 11/16/18 Leah DeWitt 11/16/18

EpiSmart™ Clinical Data Published in JCRS

Read More

EpiPrep™ Patent Is Issued

Leah DeWitt 10/17/18 Leah DeWitt 10/17/18

EpiPrep™ Patent Is Issued

Read More

EpiSmart™ Patents Issued

Leah DeWitt 4/18/17 Leah DeWitt 4/18/17

EpiSmart™ Patents Issued

Read More